Cargando…
Striking efficacy of a vaccine targeting TOP2A for triple-negative breast cancer immunoprevention
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that has a poor prognosis. TOP2A is a key enzyme in DNA replication and is a therapeutic target for breast and other cancers. TOP2A-specific Th1-promoting epitopes with optimal binding affinity to MHC II were identified u...
Autores principales: | Lee, Sang Beom, Pan, Jing, Xiong, Donghai, Palen, Katie, Johnson, Bryon, Lubet, Ronald A., Shoemaker, Robert H., Green, Jeffrey E., Fernando, Romaine Ingrid, Sei, Shizuko, You, Ming, Wang, Yian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600249/ https://www.ncbi.nlm.nih.gov/pubmed/37880313 http://dx.doi.org/10.1038/s41698-023-00461-1 |
Ejemplares similares
-
Immunoprevention of KRAS-driven lung adenocarcinoma by a multipeptide vaccine
por: Pan, Jing, et al.
Publicado: (2017) -
Targeting Glutamine Metabolism to Enhance Immunoprevention of EGFR‐Driven Lung Cancer
por: Huang, Mofei, et al.
Publicado: (2022) -
Precision immunointerception of EGFR-driven tumorigenesis for lung cancer prevention
por: Pan, Jing, et al.
Publicado: (2023) -
Potentiation of Kras peptide cancer vaccine by avasimibe, a cholesterol modulator
por: Pan, Jing, et al.
Publicado: (2019) -
Pulmonary Aerosol Delivery of Let‐7b microRNA Confers a Striking Inhibitory Effect on Lung Carcinogenesis through Targeting the Tumor Immune Microenvironment
por: Zhang, Qi, et al.
Publicado: (2021)